154 related articles for article (PubMed ID: 3119023)
1. Near fatal drug interactions with methotrexate given for psoriasis.
Ng HW; Macfarlane AW; Graham RM; Verbov JL
Br Med J (Clin Res Ed); 1987 Sep; 295(6601):752-3. PubMed ID: 3119023
[No Abstract] [Full Text] [Related]
2. Methotrexate and trimethoprim-sulphamethoxazole.
Verbov JL
Clin Exp Dermatol; 1991 May; 16(3):231. PubMed ID: 1934583
[No Abstract] [Full Text] [Related]
3. Acute methotrexate toxicity seen as plaque psoriasis ulceration and necrosis: A diagnostic clue.
Fridlington JL; Tripple JW; Reichenberg JS; Hall CS; Diven DG
Dermatol Online J; 2011 Nov; 17(11):2. PubMed ID: 22136858
[TBL] [Abstract][Full Text] [Related]
4. Pancytopenia induced by the interaction between methotrexate and trimethoprim-sulfamethoxazole.
Thomas DR; Dover JS; Camp RD
J Am Acad Dermatol; 1987 Dec; 17(6):1055-6. PubMed ID: 3501437
[No Abstract] [Full Text] [Related]
5. Mucocutaneous ulcerations secondary to methotrexate.
Warner J; Brown A; Whitmore SE; Cowan DA
Cutis; 2008 May; 81(5):413-6. PubMed ID: 18543592
[TBL] [Abstract][Full Text] [Related]
6. Pancytopenia and methotrexate with trimethoprim-sulfamethoxazole.
Jeurissen ME; Boerbooms AM; van de Putte LB
Ann Intern Med; 1989 Aug; 111(3):261. PubMed ID: 2787612
[No Abstract] [Full Text] [Related]
7. Cutaneous erosions: a herald for impending pancytopenia in methotrexate toxicity.
Shiver MB; Hall LA; Conner KB; Brown GE; Cheung WL; Wirges ML
Dermatol Online J; 2014 Jul; 20(7):. PubMed ID: 25046458
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate toxicity presenting as cutaneous ulcerations on psoriatic plaques.
Koçak AY; Koçak O; Aslan F; Tektaş M
Cutan Ocul Toxicol; 2013 Oct; 32(4):333-5. PubMed ID: 23537374
[TBL] [Abstract][Full Text] [Related]
9. Erosion of psoriatic plaques after chronic methotrexate administration.
Kaplan DL; Olsen EA
Int J Dermatol; 1988; 27(1):59-62. PubMed ID: 3346128
[TBL] [Abstract][Full Text] [Related]
10. Two patterns of skin ulceration induced by methotrexate in patients with psoriasis.
Lawrence CM; Dahl MG
J Am Acad Dermatol; 1984 Dec; 11(6):1059-65. PubMed ID: 6512051
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate therapy for psoriasis.
JAMA; 1988 Nov; 260(20):3003-5. PubMed ID: 3184363
[No Abstract] [Full Text] [Related]
12. [Pancytopenia during treatment of rheumatoid arthritis with methotrexate after administration of trimethoprim-sulfamethoxazole].
Thevenet JP; Ristori JM; Cure H; Mizony MH; Bussiere JL
Presse Med; 1987 Sep; 16(30):1487. PubMed ID: 2957686
[No Abstract] [Full Text] [Related]
13. [Eventration and methotrexate in psoriasis].
Schmutz JL; Barbaud A; Trechot P
Ann Dermatol Venereol; 2010 Oct; 137(10):672. PubMed ID: 20932456
[No Abstract] [Full Text] [Related]
14. Ulcerations due to methotrexate toxicity in a psoriasis patient.
Souza CF; Suarez OM; Silva TF; Gorenstein AC; Quintella LP; Avelleira JC
An Bras Dermatol; 2016; 91(3):375-7. PubMed ID: 27438211
[TBL] [Abstract][Full Text] [Related]
15. Pancytopenia following low-dose oral methotrexate therapy for psoriasis.
Shupack JL; Webster GF
JAMA; 1988 Jun; 259(24):3594-6. PubMed ID: 3373706
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate-induced pancytopenia associated with co-prescription of penicillin and trimethoprim.
Sathi N; Dawson J
Clin Rheumatol; 2007 Jan; 26(1):134-5. PubMed ID: 16941195
[No Abstract] [Full Text] [Related]
17. Early-onset pancytopenia and skin ulcer following low-dose methotrexate therapy.
Hocaoglu N; Atilla R; Onen F; Tuncok Y
Hum Exp Toxicol; 2008 Jul; 27(7):585-9. PubMed ID: 18829735
[TBL] [Abstract][Full Text] [Related]
18. Low-dose methotrexate-induced skin toxicity: Keratinocyte dystrophy as a histologic marker.
Delyon J; Ortonne N; Benayoun E; Moroch J; Wolkenstein P; Sbidian E; Chosidow O
J Am Acad Dermatol; 2015 Sep; 73(3):484-90. PubMed ID: 26190242
[TBL] [Abstract][Full Text] [Related]
19. Eventration caused by methotrexate in a psoriatic patient.
Conte H; Ezzedine K; Jouary T; Hubiche T; Taieb A; Milpied B
J Eur Acad Dermatol Venereol; 2010 Jan; 24(1):76-7. PubMed ID: 19453786
[No Abstract] [Full Text] [Related]
20. [Suppression of bone marrow after drug interaction].
Spigset O; Messner T
Lakartidningen; 1993 Jun; 90(22):2138-40. PubMed ID: 8502067
[No Abstract] [Full Text] [Related]
[Next] [New Search]
